BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 36253718)

  • 1. Time optimization of gadobutrol-enhanced brain MRI for metastases and primary tumors using a dynamic contrast-enhanced imaging.
    Seo J; Lim C; Lee KY; Koh YC; Moon WJ
    BMC Med Imaging; 2022 Oct; 22(1):180. PubMed ID: 36253718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of imaging time in the magnetic resonance detection of intracerebral metastases using single dose gadobutrol.
    Jeon JY; Choi JW; Roh HG; Moon WJ
    Korean J Radiol; 2014; 15(1):145-50. PubMed ID: 24497805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic value of gadobutrol versus gadopentetate dimeglumine in enhanced MRI of brain metastases.
    Fan B; Li M; Wang X; Xu Y; Li F; Zhang L; Jiang J; Jiang Y
    J Magn Reson Imaging; 2017 Jun; 45(6):1827-1834. PubMed ID: 27696616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Efficacy of Reduced-Dose Gadobutrol Versus Standard-Dose Gadoterate for Contrast-Enhanced MRI of the CNS: An International Multicenter Prospective Crossover Trial (LEADER-75).
    Liu BP; Rosenberg M; Saverio P; Weon YC; Peters S; Ardellier FD; Boeckenhoff A; Endrikat J
    AJR Am J Roentgenol; 2021 Nov; 217(5):1195-1205. PubMed ID: 34133205
    [No Abstract]   [Full Text] [Related]  

  • 5. Magnetic resonance evaluation of brain metastases from systemic malignances with two doses of gadobutrol 1.0 m compared with gadoteridol: a multicenter, phase ii/iii study in patients with known or suspected brain metastases.
    Katakami N; Inaba Y; Sugata S; Tsurusaki M; Itoh T; Machida T; Tanaka H; Nakayama T; Morikawa T; Breuer J; Aitoku Y
    Invest Radiol; 2011 Jul; 46(7):411-8. PubMed ID: 21467949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diagnosis of cerebral metastasis with standard dose gadobutrol vs. a high dose protocol. Intraindividual evaluation of a phase II high dose study].
    Vogl TJ; Friebe CE; Balzer T; Mack MG; Steiner S; Schedel H; Pegios W; Lanksch W; Banzer D; Felix R
    Radiologe; 1995 Aug; 35(8):508-16. PubMed ID: 7568795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of cerebral metastases on magnetic resonance imaging: intraindividual comparison of gadobutrol with gadopentetate dimeglumine.
    Anzalone N; Gerevini S; Scotti R; Vezzulli P; Picozzi P
    Acta Radiol; 2009 Oct; 50(8):933-40. PubMed ID: 19626475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MRI in multiple sclerosis: an intra-individual, randomized and multicentric comparison of gadobutrol with gadoterate meglumine at 3 T.
    Saake M; Langner S; Schwenke C; Weibart M; Jansen O; Hosten N; Doerfler A
    Eur Radiol; 2016 Mar; 26(3):820-8. PubMed ID: 26123410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of gadoteric acid and gadobutrol for detection as well as morphologic and dynamic characterization of lesions on breast dynamic contrast-enhanced magnetic resonance imaging.
    Renz DM; Durmus T; Böttcher J; Taupitz M; Diekmann F; Huppertz A; Pfeil A; Maurer MH; Streitparth F; Bick U; Hamm B; Fallenberg EM
    Invest Radiol; 2014 Jul; 49(7):474-84. PubMed ID: 24637587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic yield of double-dose gadobutrol in the detection of brain metastasis: intraindividual comparison with double-dose gadopentetate dimeglumine.
    Kim ES; Chang JH; Choi HS; Kim J; Lee SK
    AJNR Am J Neuroradiol; 2010 Jun; 31(6):1055-8. PubMed ID: 20110372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. P03277-A New Approach to Achieve High-Contrast Enhancement: Initial Results of an Experimental Extracellular Gadolinium-Based Magnetic Resonance Contrast Agent.
    Fries P; Müller A; Seidel R; Robert P; Denda G; Menger MD; Schneider G; Buecker A
    Invest Radiol; 2015 Dec; 50(12):835-42. PubMed ID: 26186281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic susceptibility contrast and dynamic contrast-enhanced MRI characteristics to distinguish microcystic meningiomas from traditional Grade I meningiomas and high-grade gliomas.
    Hussain NS; Moisi MD; Keogh B; McCullough BJ; Rostad S; Newell D; Gwinn R; Foltz G; Mayberg M; Aguedan B; Good V; Fouke SJ
    J Neurosurg; 2017 Apr; 126(4):1220-1226. PubMed ID: 27285539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamic contrast-enhanced magnetic resonance imaging evaluation of VX2 carcinoma in a rabbit model: comparison of 1.0-M gadobutrol and 0.5-M gadopentetate dimeglumine.
    Chang JM; Moon WK; Cha JH; Jung EJ; Cho N; Kim SJ
    Invest Radiol; 2010 Oct; 45(10):655-61. PubMed ID: 20808238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contrast-to-Dose Relationship of Gadopiclenol, an MRI Macrocyclic Gadolinium-based Contrast Agent, Compared with Gadoterate, Gadobenate, and Gadobutrol in a Rat Brain Tumor Model.
    Robert P; Vives V; Grindel AL; Kremer S; Bierry G; Louin G; Ballet S; Corot C
    Radiology; 2020 Jan; 294(1):117-126. PubMed ID: 31660804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Gadoterate Meglumine and Gadobutrol in the MRI Diagnosis of Primary Brain Tumors: A Double-Blind Randomized Controlled Intraindividual Crossover Study (the REMIND Study).
    Maravilla KR; San-Juan D; Kim SJ; Elizondo-Riojas G; Fink JR; Escobar W; Bag A; Roberts DR; Hao J; Pitrou C; Tsiouris AJ; Herskovits E; Fiebach JB
    AJNR Am J Neuroradiol; 2017 Sep; 38(9):1681-1688. PubMed ID: 28663267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MRI and Quantitative Magnetic Susceptibility Maps of the Brain after Serial Administration of Gadobutrol: A Longitudinal Follow-up Study.
    Choi Y; Jang J; Kim J; Nam Y; Shin NY; Ahn KJ; Jeon SS; Kim BS
    Radiology; 2020 Oct; 297(1):143-150. PubMed ID: 32692298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are there differences between macrocyclic gadolinium contrast agents for brain tumor imaging? Results of a multicenter intraindividual crossover comparison of gadobutrol with gadoteridol (the TRUTH study).
    Maravilla KR; Smith MP; Vymazal J; Goyal M; Herman M; Baima JJ; Babbel R; Vaneckova M; Žižka J; Colosimo C; Urbańczyk-Zawadzka M; Mechl M; Bag AK; Bastianello S; Bueltmann E; Hirai T; Frattini T; Kirchin MA; Pirovano G
    AJNR Am J Neuroradiol; 2015 Jan; 36(1):14-23. PubMed ID: 25300984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparison of Time-intensity Curve with Gadobenatedimeglumine and Gadobutrol on Multiphase Contrast-enhanced Breast MRI].
    Komura Y; Mogi T; Shimizu F; Yatabe K; Nedate J; Kanazawa H; Kawai A
    Nihon Hoshasen Gijutsu Gakkai Zasshi; 2018; 74(4):368-374. PubMed ID: 29681604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gadolinium deposition within the paediatric brain: no increased intrinsic T1-weighted signal intensity within the dentate nucleus following the administration of a minimum of four doses of the macrocyclic agent gadobutrol.
    Young JR; Qiao J; Orosz I; Salamon N; Franke MA; Kim HJ; Pope WB
    Eur Radiol; 2018 Nov; 28(11):4882-4889. PubMed ID: 29744642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multicenter, randomized, controlled, single-blind comparison phase III study to determine the efficacy and safety of gadobutrol 1.0 M versus gadopentetate dimeglumine following single injection in patients referred for contrast-enhanced MRI of the body regions or extremities.
    Kuwatsuru R; Takahashi S; Umeoka S; Sugihara R; Zeng M; Huan Y; Peng W; Ma L; Guo L; Teng G; Yao W; Tozaki M; Endo M; Kaji S; Ro T; Tae Hahn S; Chul Kang B; Nishimura H; Sugawara Y; Katakami N; Breuer J; Aitoku Y
    J Magn Reson Imaging; 2015 Feb; 41(2):404-13. PubMed ID: 24692302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.